By Izzy Wood (Drug Target Review)2023-06-08T15:00:39
Japanese researchers now reveal a new way of activating GPCR by triggering shape changes in the intracellular region of the receptor. This new process can help researchers design drugs with fewer or no side effects.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2025-05-14T14:30:00
Sponsored by Abzena
2025-04-22T14:58:00
Sponsored by Takara Bio USA
2024-01-26T13:22:42
Sponsored by bit.bio
2023-05-18T10:39:07
Sponsored by BPS Bioscience
2026-06-02T15:00:00 2026-06-02T16:00:00
Sponsored by Danaher Life Sciences
2024-02-08T11:07:39
Sponsored by Samplix ApS
Site powered by Webvision Cloud